Fig. 11
From: Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends

Design of dual HDAC-HSP90 inhibitor
From: Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends

Design of dual HDAC-HSP90 inhibitor